PKC-induced overproduction of ROS mainly depends on the activation of NADPH oxidase (Figures 2, 3), which has been verified by the fact that treatment with the inhibitor of PKC reduced NADPH oxidase-produced ROS and rescued the heart from DCM (70–72). This evidence concerns the gene FMO5 and familial dilated cardiomyopathy.